Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)-Reference-Cited by-同舟云学术

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)

Published:2013-05 Issue:9880 Volume:381 Page:1835-1843
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cho Eun-Ae,Moloney Fergal J,Cai Hong,Au-Yeung Annie,China Carlos,Scolyer Richard A,Yosufi Benafsha,Raftery Mark J,Deng Jason Z,Morton Stephen W,Hammond Paula T,Arkenau Hendrik-Tobias,Damian Diona L,Francis Douglas J,Chesterman Colin N,Barnetson Ross St C,Halliday Gary M,Khachigian Levon M

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Biology of basal cell carcinoma (part I);Miller;J Am Acad Dermatol,1991

2. Biology of basal cell carcinoma (part II);Miller;J Am Acad Dermatol,1991

3. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms;Lacour;Br J Dermatol,2002

4. Cancer in Australia 2001,2004

5. Incidence estimate of nonmelanoma skin cancer in the United States, 2006;Rogers;Arch Dermatol,2010

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine development: Current trends and technologies;Life Sciences;2024-01

2. A scientific debate: The sword that cleaves chaos of DNAzyme catalysis research;Biomedical Technology;2023-12

3. Facilitated Synthetic Access to Boronic Acid-Modified Nucleoside Triphosphates and Compatibility with Enzymatic DNA Synthesis;Synlett;2023-11-16

4. New insights into the therapeutic approaches for the treatment of tauopathies;Neural Regeneration Research;2023-09-22

5. A promising nucleic acid therapy drug: DNAzymes and its delivery system;Frontiers in Molecular Biosciences;2023-09-11